XM does not provide services to residents of the United States of America.
B
B

BayerAG

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

Bayer AG Says Elinzanetant Significantly Reduces Frequency And Severity Of Moderate To Severe Hot Flashes Associated With Menopause

BRIEF-Bayer AG Says Elinzanetant Significantly Reduces Frequency And Severity Of Moderate To Severe Hot Flashes Associated With Menopause May 16 (Reuters) - Bayer AG BAYGn.DE : ELINZANETANT SIGNIFICANTLY REDUCES FREQUENCY AND SEVERITY OF MODERATE TO SEVERE HOT FLASHES ASSOCIATED WITH MENOPAUSE ELINZANETANT SUCCESSFULLY MET ALL FOUR PRIMARY ENDPOINT
B

Ag inputs sales seen at good level in the US, not as good in South America

Ag inputs sales seen at good level in the US, not as good in South America By Marcelo Teixeira NEW YORK, May 16 (Reuters) - Sales of agricultural inputs such as fertilizers and crop care products have been near normal in the United States despite lower grain prices, while they are not as good in South America, according to agricultural input producers.
B
C

Bayer AG: Starts Phase I Study With 225Ac-Psma-Trillium In Advanced Metastatic Prostate Cancer

BRIEF-Bayer AG: Starts Phase I Study With 225Ac-Psma-Trillium In Advanced Metastatic Prostate Cancer May 15 (Reuters) - Bayer AG BAYGn.DE : STARTS PHASE I STUDY WITH NOVEL TARGETED RADIONUCLIDE THERAPY 225AC-PSMA-TRILLIUM IN ADVANCED METASTATIC PROSTATE CANCER Source text for Eikon: [ID:] Further company coverage: BAYGn.DE Reporting by Berlin Newsr
B

Europe eyes flat start, eyes on corporate Germany

LIVE MARKETS-Europe eyes flat start, eyes on corporate Germany Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com EUROPE EYES FLAT START, EYES ON CORPORATE GERMANY Shares in Europe were set for another muted session on Tuesday, with futures stuck around parity, as traders sat on the sidelines ahead of U.S.
B
B
P
R
V
V
A
U

Bayer's first-quarter adjusted profit falls less than expected

UPDATE 2-Bayer's first-quarter adjusted profit falls less than expected Recasts, adds details, background on job cuts from paragraph 11 By Ludwig Burger FRANKFURT, May 14 (Reuters) - Bayer BAYGn.DE beat first-quarter analyst forecasts as it reported a slight drop in adjusted earnings on Tuesday, providing a respite for the CEO's turnaround efforts.
B

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.